31. 12 BIOLOGY OF MDS DISEASE PROGRESSION. (April 2015) Authors: Papaemmanuil, E. Journal: Leukemia research Issue: Volume 39(2015:Apr.) Supplement 1 Page Start: S4 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
32. 120 RESULTS OF THE MULTICENTER, PHASE II STUDY OF THE SAFETY OF LENALIDOMIDE MONOTHERAPY IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS) ASSOCIATED WITH AN ISOLATED DEL(5Q). Issue 1 (April 2015) Authors: Schuler, E.; Schemenau, J.; Giagounidis, A.; Haase, D.; Büsche, G.; Platzbecker, U.; Nolte, F.; Götze, K.; Schlenk, R.F.; Ganser, A.; Letsch, A.; Lübbert, M.; Schafhausen, P.; Bug, G.; Germing, U. Journal: Leukemia research Issue: Volume 39:Issue 1(2015:Jan.) Page Start: S62 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
33. 121 PERIPHERAL BLOOD (PB) WILMS' TUMOR 1 (WT1) EXPRESSION QUANTIFIED BY A STANDARDIZED EUROPEAN LEUKEMIA NET (ELN)-CERTIFIED ASSAY AS PROGNOSTIC AND MINIMAL RESIDUAL DISEASE (MRD) MARKER IN MDS. (April 2015) Authors: Schroeder, T.; Pechtel, S.; Lamers, M.; Dienst, A.; Schuler, E.; Rachlis, E.; Wegener, N.; Kündgen, A.; Kondakci, M.; Fenk, R.; Haas, R.; Germing, U.; Kobbe, G. Journal: Leukemia research Issue: Volume 39(2015:Apr.) Supplement 1 Page Start: S62 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
34. 122 PROGNOSTIC FACTORS OF INFECTIONS AND EFFECT OF PRIMARY ANTI-INFECTIOUS PROPHYLAXIS IN MDS PATIENTS TREATED WITH AZACITIDINE (AZA): A PROSPECTIVE STUDY. (April 2015) Authors: Sebert, M.; Aguilar, C.; Ades, L.; Chevret, S.; Lortholary, O.; Fenaux, P. Journal: Leukemia research Issue: Volume 39(2015:Apr.) Supplement 1 Page Start: S63 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
35. 123 AZACITIDINE (AZA) COMBINED WITH IDARUBICIN (IDA) IN HIGHER RISK MDS (HRMDS) – RESULTS OF A PHASE I/II STUDY BY THE GFM. Issue 1 (April 2015) Authors: Sebert, M.; Ades, L.; Stamatoullas, A.; Braun, T.; Delaunay, J.; de Renzis, B.; Jeddi, R.; Meddeb, B.; Berger, M. Hunault; Samey, B.; Chermat, F.; Chaffaut, C.; Chevert, S.; Fenaux, P. Journal: Leukemia research Issue: Volume 39:Issue 1(2015:Jan.) Page Start: S63 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
36. 124 AZACITIDINE VERSUS CONVENTIONAL CARE REGIMENS (CCR) IN OLDER PATIENTS WITH NEWLY DIAGNOSED AML (>30% MARROW BLASTS) WITH MYELODYSPLASIA-RELATED CHANGES: SUBGROUP ANALYSIS OF THE AZA-AML-001 STUDY. (April 2015) Authors: Seymour, J.F.; Döhner, H.; Butrym, A.; Wierzbowska, A.; Selleslag, D.; Jang, J.H.; Cavenagh, J.D.; Kumar, R.; Schuh, A.C.; Candoni, A.; Récher, C.; Sandhu, I.; del Castillo, T. Bernal; Al-Ali, H.K.; Martinelli, G.; Falantes, J.; Nopenney, R.; Stone, R.M.; Minden, M.D.; McIntyre, H. Journal: Leukemia research Issue: Volume 39(2015:Apr.) Supplement 1 Page Start: S63 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
37. 125 FEBRILE EPISODES IN PATIENTS WITH MDS TREATED WITH AZACITIDINE. A THREE YEAR MONOCENTRIC RETROSPECTIVE STUDY. Issue 1 (April 2015) Authors: Stamatoullas, A.; Rezine, I.; Menard, A.L.; Lanic, H.; David, M.; Daliphard, S.; Penther, D.; Cassuto, O.; Lenain, P.; Lepretre, S.; Contentin, N.; Lemasle, E.; Cardinael, N.; Fontura, M.L.; Fronville, C.; Jardin, F.; Bastard, C.; Tilly, H. Journal: Leukemia research Issue: Volume 39:Issue 1(2015:Jan.) Page Start: S64 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
38. 126 GERIATRIC ASSESSMENT DEFINES IMPAIRMENTS AND CLINICAL OUTCOME IN MYELODYSPLASTIC SYNDROMES. Issue 1 (April 2015) Authors: Stauder, R.; Spross, J.M.; Augschöll, J. Journal: Leukemia research Issue: Volume 39:Issue 1(2015:Jan.) Page Start: S65 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
39. 127 HC-G REGIMEN CHEMOTHERAPY IN REMISSION INDUCTION FOR ELDERLY PATIENTS WITH ACUTE MYELOID LEUKEMIA AND HIGH RISK MYELODYSPLASTIC SYNDROME. (April 2015) Authors: Wang, J.L.; He, A.L.; Zhang, W.G.; Cuan, T. Journal: Leukemia research Issue: Volume 39(2015:Apr.) Supplement 1 Page Start: S65 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
40. 128 SINGLE CENTER EXPERIENCE OF RIC BASED ALLOGENIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN 100 PATIENTS WITH MDS. Issue 1 (April 2015) Authors: Blaise, D.; Saillard, C.; Fürst, S.; Faucher, C.; Prebet, T.; El Cheikh, J.; Castagna, L.; Charbonnier, A.; Granata, A.; Rey, J.; Devillier, R.; Mohty, B.; Arnoulet, C.; Moziconnaci, M.J.; Chabannon, C.; Vey, N. Journal: Leukemia research Issue: Volume 39:Issue 1(2015:Jan.) Page Start: S66 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗